Diphtheria Treatment Market

Diphtheria treatment market information: by product type (Tetanus immune globulin, Tetanus toxoid, Tetanus-diphtheria, Diphtheria toxoid and pertussis) by treatment (antitoxin, antibiotics, others) by end users - Global Forecast to 2023

Study objectives:

• To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global diphtheria treatment market.


• To provide insights about factors affecting the market growth.


• To analyze the global diphtheria treatment market based on various factors - Price Analysis, Supply Chain analysis, Porters Five Force analysis etc.


• To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies - the Americas, Europe, Asia Pacific along with Middle East & Africa and their countries.


• To provide country level analysis of the market with respect to the current market size and future growth prospects.


• To provide country level analysis of the market which includes segmentation by product type, treatment and end users.


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market.


• To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments that are currently taking place in the global diphtheria treatment markets.

Intended Audience

• Global diphtheria treatment, manufacturers & suppliers


• Research and development (R&D) companies


• Market research and consulting service providers


• Academic institutes and universities

Market Synopsis of Global Diphtheria Treatment Market:

Market scenario:

Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever leading to narrowing of the air passages and barking cough. Diphtheria may also affect the skin, eyes, or genitals and may cause myocarditis, bleeding and kidney problems.

The global diphtheria treatment market is growing at a slow rate due to high effectiveness and efficiency of the vaccine, falling profitability of vaccine manufacture, side effects associated with vaccines such as type A immune reaction and allergies, variability in the efficacy of vaccines. Financial restraints such as falling returns on investment and the resultant exit of a number of players from vaccine manufacture will affect the future growth of vaccines.

Considering all these factors the market for diphtheria treatment is expected to reach $ 5 billion by the end of 2023, this market is projected to be growing at a CAGR of ~ 3.2 % during 2017-2023.

Figure 1         Global Diphtheria treatment Market by End Users, 2016 (% Market Share)

Segments:

The global diphtheria treatment market is segmented on the basis of product type and end users. Based on product type, the market has been segmented as Tetanus Immune Globulin (TIG), Tetanus Toxoid (TT), Tetanus-diphtheria (Td), Diphtheria Toxoid and Pertussis (DTaP). Based on the treatment, the market has been segmented as antitoxin, antibiotics, macrolides and others. Based on the end users, the market has been segmented as hospitals and clinics, academics and research, and others.

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global diphtheria treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration. Asia Pacific region is expected to overtake the developed regions in the near future.

Key players of Global Diphtheria treatment Market:

Key players profiled in the report are Taj Pharmaceuticals Limited, Bharat Pharmaceuticals, GSK, Sanofi-Pasteur, Merck & Co., Shanghai Institute of Biological Products, Wuhan Institute of Biological Products, Serum Institute of India, Wyeth, Chiron Pharmaceutical Pvt Ltd. and others.

The report for Global Diphtheria treatment Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.